QY Research > レポート一覧 > メディカルケア > 変形性関節症の再生治療世界市場の発展状況と動向 2024-2030

変形性関節症の再生治療世界市場の発展状況と動向 2024-2030

英文タイトル: Global Regenerative Therapies for Osteoarthritis Market Insights, Forecast to 2030

変形性関節症の再生治療世界市場の発展状況と動向 2024-2030
  • レポートID:276969
  • 発表時期:2024-04-25
  • 訪問回数:117
  • ページ数:113
  • レポート形式:PDF
  • レポート言語:英語、日本語
  • グラフ数:133
  • レポートカテゴリ: メディカルケア

販売価格(消費税別)

販売価格(消費税別)

  •  
  • 個人版

    詳細
  • マルチユーザー版

    詳細
  • 企業版

    詳細

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

英語版
日本語版
英語と日本語版

価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。

shenQingYangBen

お見積

shenQingYangBen

サンプルお申込み

※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

biaoTi

概要

本報告書は変形性関節症の再生治療市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは変形性関節症の再生治療の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の変形性関節症の再生治療市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは変形性関節症の再生治療のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に変形性関節症の再生治療市場を分類しています。本研究に含まれる主な企業は:Acelity、Mesoblast、Nuo Therapeutics、Astellas Pharma、Organovo、Orgenesis、Sanofi、Athersys、Takeda、Cytori Therapeutics

地域別市場区分、地域別分析は以下の通り:
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント:
Cell Therapy
Tissue Engineering
Gene Therapy

用途別の市場セグメント:
Hospitals
Ambulatory Surgical Centers
Orthopaedic Clinics
Research Institutes

レポートの詳細内容
世界の変形性関節症の再生治療市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、変形性関節症の再生治療タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の変形性関節症の再生治療収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の変形性関節症の再生治療市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、変形性関節症の再生治療市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

変形性関節症の再生治療のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
1章:変形性関節症の再生治療のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(20192030
2章:変形性関節症の再生治療の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(20192030
3変形性関節症の再生治療企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(20192030
4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(20192024
5章:変形性関節症の再生治療の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(20192030
6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(20192030
8章:中国の種類別、および用途別、各セグメントの収益。(20192030
9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(20192030
10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(20192030
11章:変形性関節症の再生治療の主要企業の概要を提供し、製品の説明と仕様、変形性関節症の再生治療の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(20192024
12章:アナリストの見解/結論

biaoTi

概要

Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone.

Market Analysis and Insights: Global Regenerative Therapies for Osteoarthritis Market
The global Regenerative Therapies for Osteoarthritis market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market.

Report Covers:
This report presents an overview of global market for Regenerative Therapies for Osteoarthritis market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Regenerative Therapies for Osteoarthritis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Regenerative Therapies for Osteoarthritis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Regenerative Therapies for Osteoarthritis revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Regenerative Therapies for Osteoarthritis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Regenerative Therapies for Osteoarthritis revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Acelity, Mesoblast, Nuo Therapeutics, Astellas Pharma, Organovo, Orgenesis, Sanofi, Athersys and Takeda, etc.

Market Segmentation
By Company
    Acelity
    Mesoblast
    Nuo Therapeutics
    Astellas Pharma
    Organovo
    Orgenesis
    Sanofi
    Athersys
    Takeda
    Cytori Therapeutics

Segment by Type
    Cell Therapy
    Tissue Engineering
    Gene Therapy

Segment by Application
    Hospitals
    Ambulatory Surgical Centers
    Orthopaedic Clinics
    Research Institutes

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Regenerative Therapies for Osteoarthritis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Regenerative Therapies for Osteoarthritis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Regenerative Therapies for Osteoarthritis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
biaoTi

総目録

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Gene Therapy
1.3 Market by Application
1.3.1 Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Orthopaedic Clinics
1.3.5 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global Regenerative Therapies for Osteoarthritis Market Perspective (2019-2030)
2.2 Global Regenerative Therapies for Osteoarthritis Growth Trends by Region
2.2.1 Regenerative Therapies for Osteoarthritis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Regenerative Therapies for Osteoarthritis Historic Market Size by Region (2019-2024)
2.2.3 Regenerative Therapies for Osteoarthritis Forecasted Market Size by Region (2025-2030)
2.3 Regenerative Therapies for Osteoarthritis Market Dynamics
2.3.1 Regenerative Therapies for Osteoarthritis Industry Trends
2.3.2 Regenerative Therapies for Osteoarthritis Market Drivers
2.3.3 Regenerative Therapies for Osteoarthritis Market Challenges
2.3.4 Regenerative Therapies for Osteoarthritis Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue Regenerative Therapies for Osteoarthritis by Players
3.1.1 Global Regenerative Therapies for Osteoarthritis Revenue by Players (2019-2024)
3.1.2 Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Players (2019-2024)
3.2 Global Regenerative Therapies for Osteoarthritis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Regenerative Therapies for Osteoarthritis, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio
3.4.1 Global Regenerative Therapies for Osteoarthritis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Therapies for Osteoarthritis Revenue in 2023
3.5 Global Key Players of Regenerative Therapies for Osteoarthritis Head office and Area Served
3.6 Global Key Players of Regenerative Therapies for Osteoarthritis, Product and Application
3.7 Global Key Players of Regenerative Therapies for Osteoarthritis, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Regenerative Therapies for Osteoarthritis Breakdown Data by Type
4.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Type (2019-2024)
4.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2025-2030)

5 Regenerative Therapies for Osteoarthritis Breakdown Data by Application
5.1 Global Regenerative Therapies for Osteoarthritis Historic Market Size by Application (2019-2024)
5.2 Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2025-2030)

6 North America
6.1 North America Regenerative Therapies for Osteoarthritis Market Size (2019-2030)
6.2 North America Regenerative Therapies for Osteoarthritis Market Size by Type
6.2.1 North America Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024)
6.2.2 North America Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030)
6.2.3 North America Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
6.3 North America Regenerative Therapies for Osteoarthritis Market Size by Application
6.3.1 North America Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024)
6.3.2 North America Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030)
6.3.3 North America Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
6.4 North America Regenerative Therapies for Osteoarthritis Market Size by Country
6.4.1 North America Regenerative Therapies for Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Regenerative Therapies for Osteoarthritis Market Size by Country (2019-2024)
6.4.3 North America Regenerative Therapies for Osteoarthritis Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada

7 Europe
7.1 Europe Regenerative Therapies for Osteoarthritis Market Size (2019-2030)
7.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Type
7.2.1 Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024)
7.2.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030)
7.2.3 Europe Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
7.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Application
7.3.1 Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024)
7.3.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030)
7.3.3 Europe Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
7.4 Europe Regenerative Therapies for Osteoarthritis Market Size by Country
7.4.1 Europe Regenerative Therapies for Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2019-2024)
7.4.3 Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China Regenerative Therapies for Osteoarthritis Market Size (2019-2030)
8.2 China Regenerative Therapies for Osteoarthritis Market Size by Type
8.2.1 China Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024)
8.2.2 China Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030)
8.2.3 China Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
8.3 China Regenerative Therapies for Osteoarthritis Market Size by Application
8.3.1 China Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024)
8.3.2 China Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030)
8.3.3 China Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Regenerative Therapies for Osteoarthritis Market Size (2019-2030)
9.2 Asia Regenerative Therapies for Osteoarthritis Market Size by Type
9.2.1 Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024)
9.2.2 Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030)
9.2.3 Asia Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
9.3 Asia Regenerative Therapies for Osteoarthritis Market Size by Application
9.3.1 Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024)
9.3.2 Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030)
9.3.3 Asia Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
9.4 Asia Regenerative Therapies for Osteoarthritis Market Size by Region
9.4.1 Asia Regenerative Therapies for Osteoarthritis Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Regenerative Therapies for Osteoarthritis Market Size by Region (2019-2024)
9.4.3 Asia Regenerative Therapies for Osteoarthritis Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Type
10.2.1 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Application
10.3.1 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Country
10.4.1 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries

11 Key Players Profiles
11.1 Acelity
11.1.1 Acelity Company Details
11.1.2 Acelity Business Overview
11.1.3 Acelity Regenerative Therapies for Osteoarthritis Introduction
11.1.4 Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.1.5 Acelity Recent Developments
11.2 Mesoblast
11.2.1 Mesoblast Company Details
11.2.2 Mesoblast Business Overview
11.2.3 Mesoblast Regenerative Therapies for Osteoarthritis Introduction
11.2.4 Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.2.5 Mesoblast Recent Developments
11.3 Nuo Therapeutics
11.3.1 Nuo Therapeutics Company Details
11.3.2 Nuo Therapeutics Business Overview
11.3.3 Nuo Therapeutics Regenerative Therapies for Osteoarthritis Introduction
11.3.4 Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.3.5 Nuo Therapeutics Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Regenerative Therapies for Osteoarthritis Introduction
11.4.4 Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.4.5 Astellas Pharma Recent Developments
11.5 Organovo
11.5.1 Organovo Company Details
11.5.2 Organovo Business Overview
11.5.3 Organovo Regenerative Therapies for Osteoarthritis Introduction
11.5.4 Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.5.5 Organovo Recent Developments
11.6 Orgenesis
11.6.1 Orgenesis Company Details
11.6.2 Orgenesis Business Overview
11.6.3 Orgenesis Regenerative Therapies for Osteoarthritis Introduction
11.6.4 Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.6.5 Orgenesis Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Regenerative Therapies for Osteoarthritis Introduction
11.7.4 Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.7.5 Sanofi Recent Developments
11.8 Athersys
11.8.1 Athersys Company Details
11.8.2 Athersys Business Overview
11.8.3 Athersys Regenerative Therapies for Osteoarthritis Introduction
11.8.4 Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.8.5 Athersys Recent Developments
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Regenerative Therapies for Osteoarthritis Introduction
11.9.4 Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.9.5 Takeda Recent Developments
11.10 Cytori Therapeutics
11.10.1 Cytori Therapeutics Company Details
11.10.2 Cytori Therapeutics Business Overview
11.10.3 Cytori Therapeutics Regenerative Therapies for Osteoarthritis Introduction
11.10.4 Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024)
11.10.5 Cytori Therapeutics Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

biaoTi

表と図のリスト

List of Tables
    Table 1. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Cell Therapy
    Table 3. Key Players of Tissue Engineering
    Table 4. Key Players of Gene Therapy
    Table 5. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 6. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Regenerative Therapies for Osteoarthritis Market Size by Region (2019-2024) & (US$ Million)
    Table 8. Global Regenerative Therapies for Osteoarthritis Market Share by Region (2019-2024)
    Table 9. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 10. Global Regenerative Therapies for Osteoarthritis Market Share by Region (2025-2030)
    Table 11. Regenerative Therapies for Osteoarthritis Market Trends
    Table 12. Regenerative Therapies for Osteoarthritis Market Drivers
    Table 13. Regenerative Therapies for Osteoarthritis Market Challenges
    Table 14. Regenerative Therapies for Osteoarthritis Market Restraints
    Table 15. Global Regenerative Therapies for Osteoarthritis Revenue by Players (2019-2024) & (US$ Million)
    Table 16. Global Regenerative Therapies for Osteoarthritis Revenue Share by Players (2019-2024)
    Table 17. Global Top Regenerative Therapies for Osteoarthritis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2023)
    Table 18. Global Regenerative Therapies for Osteoarthritis Industry Ranking 2022 VS 2023 VS 2024
    Table 19. Global 5 Largest Players Market Share by Regenerative Therapies for Osteoarthritis Revenue (CR5 and HHI) & (2019-2024)
    Table 20. Global Key Players of Regenerative Therapies for Osteoarthritis, Headquarters and Area Served
    Table 21. Global Key Players of Regenerative Therapies for Osteoarthritis, Product and Application
    Table 22. Global Key Players of Regenerative Therapies for Osteoarthritis, Product and Application
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
    Table 25. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2019-2024)
    Table 26. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 27. Global Regenerative Therapies for Osteoarthritis Revenue Market Share by Type (2025-2030)
    Table 28. Global Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
    Table 29. Global Regenerative Therapies for Osteoarthritis Revenue Share by Application (2019-2024)
    Table 30. Global Regenerative Therapies for Osteoarthritis Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 31. Global Regenerative Therapies for Osteoarthritis Revenue Share by Application (2025-2030)
    Table 32. North America Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
    Table 33. North America Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030) & (US$ Million)
    Table 34. North America Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
    Table 35. North America Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030) & (US$ Million)
    Table 36. North America Regenerative Therapies for Osteoarthritis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. North America Regenerative Therapies for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
    Table 38. North America Regenerative Therapies for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
    Table 40. Europe Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030) & (US$ Million)
    Table 41. Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
    Table 42. Europe Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030) & (US$ Million)
    Table 43. Europe Regenerative Therapies for Osteoarthritis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Europe Regenerative Therapies for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
    Table 46. China Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
    Table 47. China Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030) & (US$ Million)
    Table 48. China Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
    Table 49. China Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030) & (US$ Million)
    Table 50. Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
    Table 51. Asia Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030) & (US$ Million)
    Table 52. Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
    Table 53. Asia Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030) & (US$ Million)
    Table 54. Asia Regenerative Therapies for Osteoarthritis Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 55. Asia Regenerative Therapies for Osteoarthritis Market Size by Region (2019-2024) & (US$ Million)
    Table 56. Asia Regenerative Therapies for Osteoarthritis Market Size by Region (2025-2030) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2019-2024) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Type (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Application (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 62. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size by Country (2025-2030) & (US$ Million)
    Table 64. Acelity Company Details
    Table 65. Acelity Business Overview
    Table 66. Acelity Regenerative Therapies for Osteoarthritis Product
    Table 67. Acelity Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 68. Acelity Recent Developments
    Table 69. Mesoblast Company Details
    Table 70. Mesoblast Business Overview
    Table 71. Mesoblast Regenerative Therapies for Osteoarthritis Product
    Table 72. Mesoblast Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 73. Mesoblast Recent Developments
    Table 74. Nuo Therapeutics Company Details
    Table 75. Nuo Therapeutics Business Overview
    Table 76. Nuo Therapeutics Regenerative Therapies for Osteoarthritis Product
    Table 77. Nuo Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 78. Nuo Therapeutics Recent Developments
    Table 79. Astellas Pharma Company Details
    Table 80. Astellas Pharma Business Overview
    Table 81. Astellas Pharma Regenerative Therapies for Osteoarthritis Product
    Table 82. Astellas Pharma Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 83. Astellas Pharma Recent Developments
    Table 84. Organovo Company Details
    Table 85. Organovo Business Overview
    Table 86. Organovo Regenerative Therapies for Osteoarthritis Product
    Table 87. Organovo Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 88. Organovo Recent Developments
    Table 89. Orgenesis Company Details
    Table 90. Orgenesis Business Overview
    Table 91. Orgenesis Regenerative Therapies for Osteoarthritis Product
    Table 92. Orgenesis Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 93. Orgenesis Recent Developments
    Table 94. Sanofi Company Details
    Table 95. Sanofi Business Overview
    Table 96. Sanofi Regenerative Therapies for Osteoarthritis Product
    Table 97. Sanofi Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 98. Sanofi Recent Developments
    Table 99. Athersys Company Details
    Table 100. Athersys Business Overview
    Table 101. Athersys Regenerative Therapies for Osteoarthritis Product
    Table 102. Athersys Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 103. Athersys Recent Developments
    Table 104. Takeda Company Details
    Table 105. Takeda Business Overview
    Table 106. Takeda Regenerative Therapies for Osteoarthritis Product
    Table 107. Takeda Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 108. Takeda Recent Developments
    Table 109. Cytori Therapeutics Company Details
    Table 110. Cytori Therapeutics Business Overview
    Table 111. Cytori Therapeutics Regenerative Therapies for Osteoarthritis Product
    Table 112. Cytori Therapeutics Revenue in Regenerative Therapies for Osteoarthritis Business (2019-2024) & (US$ Million)
    Table 113. Cytori Therapeutics Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Regenerative Therapies for Osteoarthritis Market Share by Type: 2023 VS 2030
    Figure 3. Cell Therapy Features
    Figure 4. Tissue Engineering Features
    Figure 5. Gene Therapy Features
    Figure 6. Global Regenerative Therapies for Osteoarthritis Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Regenerative Therapies for Osteoarthritis Market Share by Application: 2023 VS 2030
    Figure 8. Hospitals Case Studies
    Figure 9. Ambulatory Surgical Centers Case Studies
    Figure 10. Orthopaedic Clinics Case Studies
    Figure 11. Research Institutes Case Studies
    Figure 12. Regenerative Therapies for Osteoarthritis Report Years Considered
    Figure 13. Global Regenerative Therapies for Osteoarthritis Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Regenerative Therapies for Osteoarthritis Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Regenerative Therapies for Osteoarthritis Market Share by Region: 2023 VS 2030
    Figure 16. Global Regenerative Therapies for Osteoarthritis Market Share by Players in 2023
    Figure 17. Global Top Regenerative Therapies for Osteoarthritis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Therapies for Osteoarthritis as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Regenerative Therapies for Osteoarthritis Revenue in 2023
    Figure 19. North America Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
    Figure 21. North America Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
    Figure 22. North America Regenerative Therapies for Osteoarthritis Market Share by Country (2019-2030)
    Figure 23. United States Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Regenerative Therapies for Osteoarthritis Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
    Figure 27. Europe Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
    Figure 28. Europe Regenerative Therapies for Osteoarthritis Market Share by Country (2019-2030)
    Figure 29. Germany Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Regenerative Therapies for Osteoarthritis Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
    Figure 37. China Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
    Figure 38. Asia Regenerative Therapies for Osteoarthritis Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
    Figure 40. Asia Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
    Figure 41. Asia Regenerative Therapies for Osteoarthritis Market Share by Region (2019-2030)
    Figure 42. Japan Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Regenerative Therapies for Osteoarthritis Market Share by Country (2019-2030)
    Figure 52. Brazil Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Regenerative Therapies for Osteoarthritis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Acelity Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 59. Mesoblast Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 60. Nuo Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 61. Astellas Pharma Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 62. Organovo Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 63. Orgenesis Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 64. Sanofi Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 65. Athersys Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 66. Takeda Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 67. Cytori Therapeutics Revenue Growth Rate in Regenerative Therapies for Osteoarthritis Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
当社から購入のメリット
サンプル提供

01. サンプル提供

ご購入前にサンプル(英語、日本語)が提供可能。

カスタマイズサービス

02. カスタマイズサービス

レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。

プロフェッショナルな日本語翻訳

03. プロフェッショナルな日本語翻訳

AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。

多言語コミュニケーション

04. 多言語コミュニケーション

日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。

 お支払方法

05. お支払方法

銀行振込(納品後、ご請求書送付)。

アフターサービス

06. アフターサービス

ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。

ご注文方法

請求書払いの場合:

  • yuan01

    レポート選択

  • yuan01

    見積もり依頼

  • yuan01

    メールでのご注文

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)

  • yuan01

    決済(後払い)

クレジットカード決済の場合:

  • yuan01

    レポート選択

  • yuan01

    ウェブサイトでのご注文

  • yuan01

    決済

  • yuan01

    入手(英語版は2〜4営業日、日本語版は8〜10営業日)